These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. Szuber N; Orazi A; Tefferi A Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693 [TBL] [Abstract][Full Text] [Related]
4. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Kim SY; Song IC; Kim J; Kwon GC Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470 [TBL] [Abstract][Full Text] [Related]
5. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Qian Y; Chen Y; Li X Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276 [TBL] [Abstract][Full Text] [Related]
6. What's different about atypical CML and chronic neutrophilic leukemia? Dao KH; Tyner JW Hematology Am Soc Hematol Educ Program; 2015; 2015():264-71. PubMed ID: 26637732 [TBL] [Abstract][Full Text] [Related]
7. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I. Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature. Wang L; Du F; Zhang HM; Wang HX Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341 [TBL] [Abstract][Full Text] [Related]
12. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq. Sheng G; Zhang J; Zeng Z; Pan J; Wang Q; Wen L; Xu Y; Wu D; Chen S Cancer Genet; 2017 Oct; 216-217():16-19. PubMed ID: 29025591 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Ouyang Y; Qiao C; Chen Y; Zhang SJ Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919 [TBL] [Abstract][Full Text] [Related]
15. Current and evolving understanding of atypical chronic myeloid leukemia. Schwartz LC; Mascarenhas J Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497 [TBL] [Abstract][Full Text] [Related]
16. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review. Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671 [TBL] [Abstract][Full Text] [Related]
17. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659 [TBL] [Abstract][Full Text] [Related]
18. Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib. Ammatuna E; Eefting M; van Lom K; Kavelaars FG; Valk PJ; Touw IP Ann Hematol; 2015 May; 94(5):879-80. PubMed ID: 25491280 [No Abstract] [Full Text] [Related]